REGULATION OF IL4 SECRETION BY INVARIANT T CELLS
恒定 T 细胞对 IL4 分泌的调节
基本信息
- 批准号:6632073
- 负责人:
- 金额:$ 26.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-04-01 至 2005-03-31
- 项目状态:已结题
- 来源:
- 关键词:CD3 molecule T cell receptor T lymphocyte apoptosis biological signal transduction calcium flux clone cells gene expression genetic techniques human genetic material tag insulin dependent diabetes mellitus interleukin 4 monozygotic twins pathologic process phosphatidylinositol 3 kinase phospholipase C protein biosynthesis secretion
项目摘要
The ablation of pancreatic beta cells by autoreactive T cells seen in
Type I diabetes is thought to be the result of a complex interplay
between genetic and environmental factors. In human disease, incomplete
concordance between identical twins suggests that factors other than
genetics contribute to disease progression. (1) Recent studies of
autoimmune diseases in humans and mice have demonstrated quantitative
and/or qualitative defects in an unusual population of CD4+ or CD4-CD8-,
NKRP1+ T cells that use an invariant TCRalpha (Valpha24JalphaQ) chain
paired with a restricted repertoire of TCR Vbeta chains. (2)(3) These
cells have the unique capability to secrete large amounts of
interleukin-4 (IL-4) without prior IL-4 priming, and as such, are a
candidate source of early IL-4 thought to be important in biasing a T
cell response towards a Th2 phenotype, and away from the pro-
inflammatory Th1 phenotype seen in Type 1 diabetes. The ligand
recognized by these potentially regulatory T cells is CD1d. (4) The
striking conservation of CD1d and the TCRs used by invariant T cells
between mice and humans indicate an important function for these cells
during an immune response. In a study of identical twins discordant for
Type 1 diabetes we demonstrated that there were reduced numbers of
invariant T cells and a striking defect in IL-4 production in clones
derived from the diabetic siblings. We hypothesize that IL-4 specific
changes in TCR signaling pathways occurred during the progression to
Type 1 diabetes. We propose to use Valpha24JalphaQ T cell clones raised
from discordant twins to compare and contrast signaling events and gene
expression patterns occurring after TCR engagement in order to identify
the reason(s) for the defect in IL-4 secretion seen in the diabetic
twin.
自体反应性T细胞消融胰腺细胞
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
S. Brian BRIAN Wilson其他文献
S. Brian BRIAN Wilson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('S. Brian BRIAN Wilson', 18)}}的其他基金
iNKT Cell Gene Expression and Effector Function in Type 1 Diabetes
1 型糖尿病中的 iNKT 细胞基因表达和效应器功能
- 批准号:
8319518 - 财政年份:2011
- 资助金额:
$ 26.56万 - 项目类别:
iNKT Cell Gene Expression and Effector Function in Type 1 Diabetes
1 型糖尿病中的 iNKT 细胞基因表达和效应器功能
- 批准号:
7681498 - 财政年份:2008
- 资助金额:
$ 26.56万 - 项目类别:
Regulation of Phosphoprotein Signalling in CD4+ and DN iNKT Cell Subsets
CD4 和 DN iNKT 细胞亚群中磷蛋白信号传导的调节
- 批准号:
7500313 - 财政年份:2007
- 资助金额:
$ 26.56万 - 项目类别:
Regulation of Phosphoprotein Signalling in CD4+ and DN iNKT Cell Subsets
CD4 和 DN iNKT 细胞亚群中磷蛋白信号传导的调节
- 批准号:
7237981 - 财政年份:2007
- 资助金额:
$ 26.56万 - 项目类别:
Role of CD4+ and DN CD1d-Restricted T Cells in Type 1 Diabetes
CD4 和 DN CD1d 限制性 T 细胞在 1 型糖尿病中的作用
- 批准号:
7524017 - 财政年份:2007
- 资助金额:
$ 26.56万 - 项目类别:
iNKT Cell Gene Expression and Effector Function in Type 1 Diabetes
1 型糖尿病中的 iNKT 细胞基因表达和效应器功能
- 批准号:
7185718 - 财政年份:2006
- 资助金额:
$ 26.56万 - 项目类别:
REGULATION OF IL4 SECRETION BY INVARIANT T CELLS
恒定 T 细胞对 IL4 分泌的调节
- 批准号:
6374112 - 财政年份:1999
- 资助金额:
$ 26.56万 - 项目类别:
REGULATION OF IL4 SECRETION BY INVARIANT T CELLS
恒定 T 细胞对 IL4 分泌的调节
- 批准号:
6510960 - 财政年份:1999
- 资助金额:
$ 26.56万 - 项目类别:
REGULATION OF IL4 SECRETION BY INVARIANT T CELLS
恒定 T 细胞对 IL4 分泌的调节
- 批准号:
6171071 - 财政年份:1999
- 资助金额:
$ 26.56万 - 项目类别:
相似海外基金
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
- 批准号:
23K28188 - 财政年份:2024
- 资助金额:
$ 26.56万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The molecular basis of T cell receptor cross-reactivity between MHC and MR1
MHC 和 MR1 之间 T 细胞受体交叉反应的分子基础
- 批准号:
DP240102905 - 财政年份:2024
- 资助金额:
$ 26.56万 - 项目类别:
Discovery Projects
CAREER: Understanding the Impact of Dephosphorylation Kinetics and Adapter Specificity on Synthetic T Cell Receptor Signaling and Function
职业:了解去磷酸化动力学和接头特异性对合成 T 细胞受体信号传导和功能的影响
- 批准号:
2339172 - 财政年份:2024
- 资助金额:
$ 26.56万 - 项目类别:
Continuing Grant
Special Public T Cell Receptor Sequences that Predict Outcomes for Cancer Patients
预测癌症患者预后的特殊公共 T 细胞受体序列
- 批准号:
10577518 - 财政年份:2023
- 资助金额:
$ 26.56万 - 项目类别:
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
- 批准号:
23H03498 - 财政年份:2023
- 资助金额:
$ 26.56万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Impact of T cell receptor signaling on memory CD8+ T cell stemness
T 细胞受体信号传导对记忆 CD8 T 细胞干性的影响
- 批准号:
10676407 - 财政年份:2023
- 资助金额:
$ 26.56万 - 项目类别:
T cell receptor cross-reactivity and structural basis of virus immune escape
T细胞受体交叉反应性和病毒免疫逃逸的结构基础
- 批准号:
22KK0277 - 财政年份:2023
- 资助金额:
$ 26.56万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
T-cell receptor mimic affinity reagent generation using an in vivo novel immunogen strategy
使用体内新型免疫原策略生成 T 细胞受体模拟亲和试剂
- 批准号:
10599584 - 财政年份:2023
- 资助金额:
$ 26.56万 - 项目类别:
Mechanical regulation of T cell receptor and co-receptor responses in cancer immunotherapy
癌症免疫治疗中 T 细胞受体和辅助受体反应的机械调节
- 批准号:
10530023 - 财政年份:2022
- 资助金额:
$ 26.56万 - 项目类别:
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
抑制 T 细胞受体信号转导治疗成人 T 细胞白血病淋巴瘤
- 批准号:
10684172 - 财政年份:2022
- 资助金额:
$ 26.56万 - 项目类别: